变应性鼻炎患者鼻甲手术的长期结局:系统综述与Meta分析
该系统综述与Meta分析检索MEDLINE、Embase、Cochrane Library和ClinicalTrials.gov至2021年4月,纳入18项研究共1411例患者,评估鼻甲手术治疗变应性鼻炎的长期结局与安全性。结果显示鼻塞、流涕、打喷嚏、鼻痒症状评分及鼻阻力显著下降,总鼻容积显著增加,术后1年以上改善维持,并发症发生率低。
要点
- 鼻甲手术治疗变应性鼻炎可显著降低鼻塞、流涕、打喷嚏、鼻痒症状评分及鼻阻力,并增加总鼻容积。
- 术后1年以上,鼻塞、流涕、打喷嚏的改善仍维持。
- 并发症发生率低,无任何并发症发生率的显著差异。
核心结论
- 在变应性鼻炎中,鼻甲手术与阳性结局相关,且该关联在长期随访中维持,并发症发生率低。
- 这些发现可用于指导考虑鼻甲手术的变应性鼻炎患者的术前咨询。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、Embase、Cochrane Library和ClinicalTrials.gov至2021年4月,纳入18项研究共1411例患者。
- 纳入标准为单独分析鼻甲手术、随访期超过1年、评估长期疗效、使用当前鼻甲手术方法、发表于同行评议期刊的研究。
- 由2名独立评审者进行全文评审,分歧由第三名评审者解决;采用随机效应模型合成加权均数差(WMD),使用Q统计量和I²指标评估异质性;按照PRISMA报告规范进行。
主要发现
- 鼻塞症状评分WMD为4.60(95%CI 3.43-5.76),流涕WMD为3.12(95%CI 1.97-4.28),打喷嚏WMD为2.64(95%CI 1.74-3.54),鼻痒WMD为1.75(95%CI 1.20-2.30),鼻阻力WMD为0.16(95%CI 0.08-0.24),总鼻容积WMD为0.96(95%CI 0.73-1.19)。
- 任何并发症的发生率无显著差异。
- 术后1年以上,鼻塞WMD为5.18(95%CI 3.00-7.37)、流涕WMD为3.57(95%CI 1.78-5.37)、打喷嚏WMD为2.95(95%CI 1.58-4.32)的改善维持。
临床怎么用
- 原文结论指出,这些发现可用于指导考虑鼻甲手术的变应性鼻炎患者的术前咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Turbinate surgery is an effective treatment for allergic rhinitis (AR) refractory to medical treatment. However, the long-term outcomes of turbinate surgery are still unclear and have not yet been confirmed by a meta-analysis and systematic review of the literature. OBJECTIVE: To investigate the long-term outcomes and safety of turbinate surgery in AR by performing a meta-analysis. DATA SOURCES: MEDLINE, Embase, the Cochrane Library, and ClinicalTrials.gov were searched through April 2021. STUDY SELECTION: Studies that analyzed turbinate surgery alone, had a follow-up period of more than 1 year, examined long-term efficacy of turbinate surgery, used current turbinate surgery methods, and were published in a peer-reviewed journal were included. Full-text reviews were performed by 2 independent reviewers. Conflicts were resolved by a third reviewer. DATA EXTRACTION AND SYNTHESIS: Descriptive and quantitative data were extracted; weighted mean difference (WMD) was synthesized under a random-effects model. Heterogeneity was assessed using the Q statistic and the I2 metric. This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines. MAIN OUTCOMES AND MEASURES: The long-term outcomes of turbinate surgery on subjective nasal symptoms and objective parameters. RESULTS: Of the 3962 citations retrieved, 18 studies comprising 1411 patients were included. Findings showed significantly decreased symptom scores in nasal obstruction (WMD, 4.60, 95% CI, 3.43-5.76), rhinorrhea (WMD, 3.12; 95% CI, 1.97-4.28), sneezing (WMD, 2.64; 95% CI, 1.74-3.54), itching (WMD, 1.75; 95% CI, 1.20-2.30), and nasal resistance (WMD, 0.16; 95% CI, 0.08-0.24) and a significant increased total nasal volume (WMD, 0.96; 95% CI, 0.73-1.19). There was no significant difference in the occurrence of any complication. More than 1 year after surgery, the improvements in nasal obstruction (WMD, 5.18; 95% CI, 3.00-7.37), rhinorrhea (WMD, 3.57; 95% CI, 1.78-5.37), and sneezing (WMD, 2.95; 95% CI, 1.58-4.32) were maintained. CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis, turbinate surgery was associated with positive outcomes in AR and maintained the association during long-term follow-up. The rate of complications is also low. These findings can guide the preoperative counseling of patients with AR being considered for turbinate surgery.
引用
- Park SC, Kim DH, Jun YJ, et al. Long-term Outcomes of Turbinate Surgery in Patients With Allergic Rhinitis: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 36394879. doi:10.1001/jamaoto.2022.3567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。